Literature DB >> 6857681

Pharmacokinetics of nicotine in rats after multiple-cigarette smoke exposure.

K S Rotenberg, J Adir.   

Abstract

The pharmacokinetics of nicotine and its major metabolites was evaluated in male rats after multiple-cigarette smoke exposure. A smoke-exposure apparatus was used to deliver cigarette smoke to the exposure chamber. The rats were exposed to smoke from a single cigarette every 8 hr for 14 days and to the smoke of a cigarette spiked with radiolabeled nicotine on the 15th day. Blood and urine samples were collected at timed intervals during the 10-min smoke-exposure period of the last cigarette and up to 48 hr thereafter. Nicotine, cotinine, and other polar metabolites were separated by thin-layer chromatography and quantified by liquid scintillation counting. The data were analyzed by computer fitting, and the derived pharmacokinetic parameters were compared to those observed after a single iv injection of nicotine and after a single-cigarette smoke exposure. The results indicated that the amount of nicotine absorbed from multiple-cigarette smoke was approximately 10-fold greater than that absorbed from a single cigarette. Also, unlike the single-cigarette smoke exposure experiment, nicotine plasma levels did not decay monotonically but increased after the 5th hr, and high plasma concentrations persisted for 30 hr. The rate and extent of the formation of cotinine, the major metabolite of nicotine, were decreased as compared with their values following a single-cigarette smoke exposure. It was concluded that nicotine or a constituent of tobacco smoke inhibits the formation of cotinine and may affect the biotransformation of other metabolites. Urinary excretion tended to support the conclusions that the pharmacokinetic parameters of nicotine and its metabolites were altered upon multiple as compared to single dose exposure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6857681     DOI: 10.1016/0041-008x(83)90113-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation.

Authors:  Cyril V Abobo; Jing Ma; Dong Liang
Journal:  Nicotine Tob Res       Date:  2012-02-06       Impact factor: 4.244

Review 2.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

3.  Chronic intermittent nicotine delivery via lung alveolar region-targeted aerosol technology produces circadian pharmacokinetics in rats resembling human smokers.

Authors:  Xuesi M Shao; Siyu Liu; Eon S Lee; David Fung; Hua Pei; Jing Liang; Ross Mudgway; Jingxi Zhang; Jack L Feldman; Yifang Zhu; Stan Louie; Xinmin S Xie
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

4.  Non-nicotine constituents in e-cigarette aerosol extract attenuate nicotine's aversive effects in adolescent rats.

Authors:  Andrew C Harris; Peter Muelken; Yayi Swain; Mary Palumbo; Vipin Jain; Maciej L Goniewicz; Irina Stepanov; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2019-08-01       Impact factor: 4.492

5.  Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats.

Authors:  M Pravetoni; D E Keyler; M D Raleigh; A C Harris; M G Lesage; C K Mattson; S Pettersson; P R Pentel
Journal:  Biochem Pharmacol       Date:  2011-02-17       Impact factor: 5.858

6.  Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats.

Authors:  Andrew C Harris; Christina Mattson; Mark G Lesage; Daniel E Keyler; Paul R Pentel
Journal:  Pharmacol Biochem Behav       Date:  2010-05-18       Impact factor: 3.533

7.  Constant-rate infusion of nicotine and cotinine. I. A physiological pharmacokinetic analysis of the cotinine disposition, and effects on clearance and distribution in the rat.

Authors:  J Gabrielsson; U Bondesson
Journal:  J Pharmacokinet Biopharm       Date:  1987-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.